{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:20:54Z","timestamp":1788402054797,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00228-018-02614-9","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T05:31:20Z","timestamp":1546579880000},"page":"553-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of plasma and oral fluid concentrations of mycophenolic acid and its glucuronide metabolite by LC-MS in kidney transplant patients"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-9829","authenticated-orcid":false,"given":"P\u00e2mela C. Lukasewicz","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Valladao","family":"Thiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaina Tavares","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingos Ot\u00e1vio","family":"D\u2019\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovani","family":"Gadonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmem Silvana A.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Rigon","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Eduardo","family":"Fr\u00f6ehlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"2614_CR1","unstructured":"Ferreira SAL, Echer IC, De Lucena FA (2014) Evidence from clinical practice. Nurs Diagnoses Among Kidney Transpl Recip 25"},{"key":"2614_CR2","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1111\/j.1600-6143.2009.02798.x","volume":"9","author":"BW Pinsky","year":"2009","unstructured":"Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR (2009) Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 9:2597\u20132606. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02798.x","journal-title":"Am J Transplant"},{"key":"2614_CR3","unstructured":"United Nation (2015) World population ageing. http:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/ageing\/WPA2015_Report.pdf . Accessed 20 Apr 2018"},{"key":"2614_CR4","unstructured":"ABTO (2017) Associa\u00e7\u00e3o Brasileira de Transplante de \u00d3rg\u00e3os - Registro Brasileiro de Transplantes. Sao Paulo"},{"key":"2614_CR5","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00204-014-1247-1","volume":"88","author":"CE Staatz","year":"2014","unstructured":"Staatz CE, Tett SE (2014) Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Arch Toxicol 88:1351\u20131389. https:\/\/doi.org\/10.1007\/s00204-014-1247-1","journal-title":"Arch Toxicol"},{"key":"2614_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","volume":"46","author":"CE Staatz","year":"2007","unstructured":"Staatz CE, Tett SE (2007) Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 46:13\u201358. https:\/\/doi.org\/10.2165\/00003088-200746010-00002","journal-title":"Clin Pharmacokinet"},{"key":"2614_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.clinbiochem.2007.03.006","volume":"40","author":"FA Elbarbry","year":"2007","unstructured":"Elbarbry FA, Shoker AS (2007) Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients. Clin Biochem 40:752\u2013764. https:\/\/doi.org\/10.1016\/j.clinbiochem.2007.03.006","journal-title":"Clin Biochem"},{"key":"2614_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trre.2011.01.001","volume":"25","author":"B T\u00f6nshoff","year":"2011","unstructured":"T\u00f6nshoff B, David-Neto E, Ettenger R, Filler G, van Gelder T, Goebel J, Kuypers DRJ, Tsai E, Vinks AA, Weber LT, Zimmerhackl LB (2011) Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation. Transplant Rev 25:78\u201389. https:\/\/doi.org\/10.1016\/j.trre.2011.01.001","journal-title":"Transplant Rev"},{"key":"2614_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.semarthrit.2010.05.007.PHARMACOKINETICS","volume":"40","author":"I Nowak","year":"1995","unstructured":"Nowak I, Shaw L (1995) Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clin Chem 40:307\u2013313. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.05.007.PHARMACOKINETICS","journal-title":"Clin Chem"},{"key":"2614_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/FTD.0b013e3181ba9a0e","volume":"31","author":"MJ Figurski","year":"2009","unstructured":"Figurski MJ, Korecka M, Fields L, Walig\u00f3rska T, Shaw LM (2009) High-performance liquid chromatography-mass spectroscopy\/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites. Ther Drug Monit 31:717\u2013726","journal-title":"Ther Drug Monit"},{"key":"2614_CR11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/clinchem\/41.7.1011","volume":"41","author":"LM Shaw","year":"1995","unstructured":"Shaw LM (1995) Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clin Chem 41:1011\u20131017","journal-title":"Clin Chem"},{"key":"2614_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0009-9120(00)00184-3","volume":"34","author":"LM Shaw","year":"2001","unstructured":"Shaw LM, Korecka M, DeNofrio D, Brayman KL (2001) Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients. Clin Biochem 34:17\u201322. https:\/\/doi.org\/10.1016\/S0009-9120(00)00184-3","journal-title":"Clin Biochem"},{"key":"2614_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.chroma.2012.04.008","volume":"1241","author":"MHJ Wiesen","year":"2012","unstructured":"Wiesen MHJ, Farowski F, Feldk\u00f6tter M, Hoppe B, M\u00fcller C (2012) Liquid chromatography-tandem mass spectrometry method for the quantification of mycophenolic acid and its phenolic glucuronide in saliva and plasma using a standardized saliva collection device. J Chromatogr A 1241:52\u201359. https:\/\/doi.org\/10.1016\/j.chroma.2012.04.008","journal-title":"J Chromatogr A"},{"key":"2614_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4322\/sc.2015.022","volume":"7","author":"DCM Bordin","year":"2015","unstructured":"Bordin DCM, Monedeiro FF dSS, de Campos EG et al (2015) T\u00e9cnicas de preparo de amostras biol\u00f3gicas com interesse forense. Sci Chromatogr 7:125\u2013143. https:\/\/doi.org\/10.4322\/sc.2015.022","journal-title":"Sci Chromatogr"},{"key":"2614_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/01.ftd.0000211826.65607.05","volume":"28","author":"AE Mendonza","year":"2009","unstructured":"Mendonza AE, Gohh RY, Akhlaghi F et al (2009) Analysis of mycophenolic acid in saliva using liquid chromatography tandem mass spectrometry. Ther Drug Monit 28:402\u2013406. https:\/\/doi.org\/10.1016\/j.chroma.2012.04.008","journal-title":"Ther Drug Monit"},{"key":"2614_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/FTD.0000000000000278","volume":"38","author":"R Li","year":"2016","unstructured":"Li R, Sheng X, Ma L et al (2016) Saliva and plasma monohydroxycarbamazepine concentrations in pediatric patients with epilepsy. Ther Drug Monit 38:365\u2013370. https:\/\/doi.org\/10.1097\/FTD.0000000000000278","journal-title":"Ther Drug Monit"},{"key":"2614_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jpba.2009.05.030","volume":"50","author":"B Shen","year":"2009","unstructured":"Shen B, Li S, Zhang Y et al (2009) Determination of total , free and saliva mycophenolic acid with a LC \u2013 MS \/ MS method. Application to pharmacokinetic study in healthy volunteers and renal transplant patients. J Pharm Biomed Anal 50:515\u2013521. https:\/\/doi.org\/10.1016\/j.jpba.2009.05.030","journal-title":"J Pharm Biomed Anal"},{"key":"2614_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.phrs.2015.07.012","volume":"99","author":"JB Woillard","year":"2015","unstructured":"Woillard JB, Saint-Marcoux F, Monchaud C, Youdar\u00e8ne R, Pouche L, Marquet P (2015) Mycophenolic mofetil optimized pharmacokinetic modelling, and exposure-effect associations in adult heart transplant recipients. Pharmacol Res 99:308\u2013315. https:\/\/doi.org\/10.1016\/j.phrs.2015.07.012","journal-title":"Pharmacol Res"},{"key":"2614_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.apsb.2016.11.003","volume":"7","author":"J Zhang","year":"2017","unstructured":"Zhang J, Jia M, Zuo L, Li N, Luo Y, Sun Z, Zhang X, Zhu Z (2017) Nonlinear relationship between enteric-coated mycophenolate sodium dose and mycophenolic acid exposure in Han kidney transplantation recipients. Acta Pharm Sin B 7:347\u2013352. https:\/\/doi.org\/10.1016\/j.apsb.2016.11.003","journal-title":"Acta Pharm Sin B"},{"key":"2614_CR20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jpba.2008.01.046","volume":"47","author":"L Zivanovi\u0107","year":"2008","unstructured":"Zivanovi\u0107 L, Licanski A, Zecevi\u0107 M et al (2008) Application of experimental design in optimization of solid phase extraction of mycophenolic acid and mycophenolic acid glucuronide from human urine and plasma and SPE-RP-HPLC method validation. J Pharm Biomed Anal 47:575\u2013585. https:\/\/doi.org\/10.1016\/j.jpba.2008.01.046","journal-title":"J Pharm Biomed Anal"},{"key":"2614_CR21","unstructured":"FDA (2018) Guidance for industry: bioanalytical method validation. In: U.S. Department of Health and Human Services. pp 1\u201344"},{"key":"2614_CR22","unstructured":"EMA (2012) European medicines agency. Guideline on bioanalytical method validation guideline on bioanalytical method validation. London, United Kingdom"},{"key":"2614_CR23","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/bmc.3736","volume":"30","author":"D Zhang","year":"2016","unstructured":"Zhang D, Chow DS-L, Renbarger JL (2016) Simultaneous quantification of mycophenolic acid and its glucuronide metabolites in human plasma by an UPLC-MS\/MS assay. Biomed Chromatogr 30:1648\u20131655. https:\/\/doi.org\/10.1002\/bmc.3736","journal-title":"Biomed Chromatogr"},{"key":"2614_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.clinbiochem.2014.12.005","volume":"48","author":"MT Nguyen Thi","year":"2015","unstructured":"Nguyen Thi MT, Mourad M, Capron A, Musuamba Tshinanu F, Vincent MF, Wallemacq P (2015) Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients. Clin Biochem 48:401\u2013405. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.12.005","journal-title":"Clin Biochem"},{"key":"2614_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cca.2010.09.041","volume":"412","author":"X Delavenne","year":"2011","unstructured":"Delavenne X, Juthier L, Pons B, Mariat C, Basset T (2011) UPLC MS\/MS method for quantification of mycophenolic acid and metabolites in human plasma: application to pharmacokinetic study. Clin Chim Acta 412:59\u201365. https:\/\/doi.org\/10.1016\/j.cca.2010.09.041","journal-title":"Clin Chim Acta"},{"key":"2614_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jchromb.2007.09.036","volume":"859","author":"FA Elbarbry","year":"2007","unstructured":"Elbarbry FA, Shoker AS (2007) Liquid chromatographic determination of mycophenolic acid and its metabolites in human kidney transplant plasma: pharmacokinetic application. J Chromatogr B Anal Technol Biomed Life Sci 859:276\u2013281. https:\/\/doi.org\/10.1016\/j.jchromb.2007.09.036","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"2614_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/01.ftd.0000197092.84935.ef","volume":"28","author":"A Pr\u00e9maud","year":"2006","unstructured":"Pr\u00e9maud A, Rousseau A, Picard N, Marquet P (2006) Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry. Ther Drug Monit 28:274\u2013277. https:\/\/doi.org\/10.1097\/01.ftd.0000197092.84935.ef","journal-title":"Ther Drug Monit"},{"key":"2614_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1365-2125.2006.02813.x","volume":"63","author":"M Naesens","year":"2007","unstructured":"Naesens M, Verbeke K, Vanrenterghem Y, Kuypers D (2007) Effects of gastric emptying on oral mycophenolic acid pharmacokinetics in stable renal allograft recipients. Br J Clin Pharmacol 63:541\u2013547. https:\/\/doi.org\/10.1111\/j.1365-2125.2006.02813.x","journal-title":"Br J Clin Pharmacol"},{"key":"2614_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s13318-015-0262-9","volume":"41","author":"J Sobiak","year":"2016","unstructured":"Sobiak J, Resztak M, G\u0142yda M, Szczepaniak P, Chrzanowska M (2016) Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation. Eur J Drug Metab Pharmacokinet 41:331\u2013338. https:\/\/doi.org\/10.1007\/s13318-015-0262-9","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2614_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40262-014-0213-7","volume":"54","author":"KM Tornatore","year":"2015","unstructured":"Tornatore KM, Meaney CJ, Wilding GE, Chang SS, Gundroo A, Cooper LM, Gray V, Shin K, Fetterly GJ, Prey J, Clark K, Venuto RC (2015) Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients. Clin Pharmacokinet 54:423\u2013434. https:\/\/doi.org\/10.1007\/s40262-014-0213-7","journal-title":"Clin Pharmacokinet"},{"key":"2614_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00007691-200108000-00001","volume":"23","author":"LM Shaw","year":"2001","unstructured":"Shaw LM, Holt DW, Oellerich M, Meiser B, van Gelder T (2001) Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit 23:305\u2013315","journal-title":"Ther Drug Monit"},{"key":"2614_CR32","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1365-2125.2009.03612.x","volume":"69","author":"C Sommerer","year":"2010","unstructured":"Sommerer C, M\u00fcller-Krebs S, Schaier M, Glander P, Budde K, Schwenger V, Mikus G, Zeier M (2010) Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients. Br J Clin Pharmacol 69:346\u2013357. https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03612.x","journal-title":"Br J Clin Pharmacol"},{"key":"2614_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/bmc.3120","volume":"28","author":"MH Oliveira de","year":"2014","unstructured":"de Oliveira MH, Carlos G, Bergold AM et al (2014) Determination of mazindol in human oral fluid by high performance liquid chromatography-electrospray ionization mass spectrometry. Biomed Chromatogr 28:1064\u20131069. https:\/\/doi.org\/10.1002\/bmc.3120","journal-title":"Biomed Chromatogr"},{"key":"2614_CR34","first-page":"147","volume":"27","author":"OH Drummer","year":"2006","unstructured":"Drummer OH (2006) Drug testing in oral fluid. Clin Biochem Rev 27:147\u2013159","journal-title":"Clin Biochem Rev"},{"key":"2614_CR35","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.transproceed.2004.05.043","volume":"36","author":"G Filler","year":"2004","unstructured":"Filler G, Foster J, Berard R, Mai I, Lepage N (2004) Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation. Transplant Proc 36:1327\u20131331. https:\/\/doi.org\/10.1016\/j.transproceed.2004.05.043","journal-title":"Transplant Proc"},{"key":"2614_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2215\/CJN.06050809","volume":"5","author":"P Glander","year":"2010","unstructured":"Glander P, Sommerer C, Arns W, Ariatabar T, Kramer S, Vogel EM, Shipkova M, Fischer W, Zeier M, Budde K (2010) Pharmacokinetics and pharmacodynamics of intensified versus standard dosing of mycophenolate sodium in renal transplant patients. Clin J Am Soc Nephrol 5:503\u2013511. https:\/\/doi.org\/10.2215\/CJN.06050809","journal-title":"Clin J Am Soc Nephrol"},{"key":"2614_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/0091270010368542","volume":"51","author":"T Fukuda","year":"2011","unstructured":"Fukuda T, Goebel J, Th\u00f8gersen H, Maseck D, Cox S, Logan B, Sherbotie J, Seikaly M, Vinks AA (2011) Inosine monophosphate dehydrogenase (IMPDH) activity as a Pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients. J Clin Pharmacol 51:309\u2013320. https:\/\/doi.org\/10.1177\/0091270010368542","journal-title":"J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-02614-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-02614-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-02614-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T15:18:36Z","timestamp":1605971916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-02614-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2614"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-02614-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}